NCT05489965 Gender Disparities in Voice Outcomes After Tracheoesophageal Puncture in Total Laryngectomy Patients (UC Davis)
| NCT ID | NCT05489965 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | Speech Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 12 participants |
| Start Date | 2023-05-31 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 12 participants in total. It began in 2023-05-31 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To perform a multi-site prospective study assessing, both subjectively and objectively, the gender disparities in speech outcomes of patients using TEP after total laryngectomy. The investigators hypothesize that speech outcomes, both subjective and objective measures, will be significantly poorer for female patients compared to male patients. The outcome of the study is to prospectively assess both subjective and objective gender disparities in voice and speech outcomes of patients using TEP after total laryngectomy across a multiple institutions. The investigators hypothesize that both subjective and objective measurements of voice, speech and quality of life will be poorer for female patients in comparison to male patients.
Eligibility Criteria
Inclusion Criteria: * Male and female subjects who have completed total laryngectomy and are using TEP Exclusion Criteria: * Subjects who have not completed total laryngectomy and are not using TEP
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05489965 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Speech Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05489965 currently recruiting?
Yes, NCT05489965 is actively recruiting participants. Contact the research team at jcate@health.ucsd.edu for enrollment information.
Where is the NCT05489965 trial being conducted?
This trial is being conducted at La Jolla, United States.
Who is sponsoring the NCT05489965 clinical trial?
NCT05489965 is sponsored by University of California, Davis. The trial plans to enroll 12 participants.